These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2192852)

  • 1. Combination therapy with insulin and sulfonylureas for type II diabetes.
    Bailey TS; Mezitis NH
    Diabetes Care; 1990 Jun; 13(6):687-95. PubMed ID: 2192852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials.
    Johnson JL; Wolf SL; Kabadi UM
    Arch Intern Med; 1996 Feb; 156(3):259-64. PubMed ID: 8572835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination insulin-sulfonylurea therapy.
    Lebovitz HE; Pasmantier R
    Diabetes Care; 1990 Jun; 13(6):667-75. PubMed ID: 2192850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical considerations and guidelines for dosing sulfonylureas as monotherapy or combination therapy.
    Bell DS
    Clin Ther; 2004 Nov; 26(11):1714-27. PubMed ID: 15639686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas.
    Scheen AJ; Lefèbvre PJ
    Diabetes Res Clin Pract; 1989 May; 6(4):S33-42; discussion S42-3. PubMed ID: 2666061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin in the early management of diabetic complications.
    Miles JM
    J Assoc Physicians India; 2003 May; 51():501-5. PubMed ID: 12974435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of glimepiride in the effective management of Type 2 diabetes.
    Davis SN
    J Diabetes Complications; 2004; 18(6):367-76. PubMed ID: 15531188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral hypoglycemic agents in type II diabetes mellitus.
    Lubbos H; Miller JL; Rose LI
    Am Fam Physician; 1995 Nov; 52(7):2075-8. PubMed ID: 7484707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin plus a sulfonylurea agent for treating type 2 diabetes.
    Peters AL; Davidson MB
    Ann Intern Med; 1991 Jul; 115(1):45-53. PubMed ID: 1828656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination use of sulfonylureas and insulin in the treatment of noninsulin-dependent diabetes mellitus.
    Montgomery PA
    Pharmacotherapy; 1992; 12(4):292-9. PubMed ID: 1518728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin: either alone or combined with oral hypoglycemic agents.
    Firth RG
    Prim Care; 1988 Sep; 15(3):665-83. PubMed ID: 3054969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of sulfonylureas: a United Kingdom Prospective Diabetes Study perspective.
    Holman RR
    Metabolism; 2006 May; 55(5 Suppl 1):S2-5. PubMed ID: 16631806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sulfonylureas with insulin in type 2 diabetes mellitus.
    Kabadi MU; Kabadi UM
    Ann Pharmacother; 2003 Nov; 37(11):1572-6. PubMed ID: 14565810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complementing insulin therapy to achieve glycemic control.
    Barnett AH
    Adv Ther; 2013 Jun; 30(6):557-76. PubMed ID: 23797471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of current therapeutic options in type 2 diabetes. Rationale for combining oral agents with insulin therapy.
    Buse JB
    Diabetes Care; 1999 Apr; 22 Suppl 3():C65-70. PubMed ID: 10189565
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 18. [Oral antidiabetic agents: recent aspects].
    Keller U; Berger W
    Schweiz Med Wochenschr; 1983 Apr; 113(17):645-50. PubMed ID: 6191388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelines.
    Tiengo A; Del Prato S
    Diabetes Res Clin Pract; 1988; 4 Suppl 1():75-81. PubMed ID: 3042339
    [No Abstract]   [Full Text] [Related]  

  • 20. Pioglitazone and sulfonylureas: effectively treating type 2 diabetes.
    Hanefeld M
    Int J Clin Pract Suppl; 2007 Jun; 61(153):20-7. PubMed ID: 17594390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.